期刊文献+

胸腔积液CA125检测的临床意义 被引量:9

Clinical significance of pleural effusion CA125 inspection
下载PDF
导出
摘要 目的探讨胸腔积液CA125检测的临床意义。方法选择2010年1月至2010年10月在我院住院的胸腔积极患者500例,所有患者在入院后第1次胸腔积液穿刺标本。经过临床和病理确诊后对症治疗2~3周后,再次收集胸腔积液,进行CA125水平检测。结果炎性胸腔积液患者血清和胸腔积液中的CA125水平增加不显著,与及癌性和结核性性胸腔积液组相比,差异有统计学意义(P<0.05),结核性和癌性胸腔积极患者的血清和胸腔积液的CA125水平都显著升高,两者差异无统计学意义(P>0.05),而且胸腔积液中的CA125水平略高于血清。结核性胸腔积液患者与自身治疗前比较显著下降(P<0.01);恶性胸腔积液患者与自身治疗前比较无统计学意义(P>0.05),而且胸腔积液中的CA125下降幅度比血清较慢。结论 CA125可以作为诊断和治疗结核性胸腔积液的观察指标。 To explore the clinical significance of pleural effusion CA125 inspection,500 patients with pleural effusion were recruited.All patients underwent paracentesis for collect the pleural effusion at beginning of their admission,and treated for 2 or 3 weeks before the second paracentesis.The pleural effusion collected at different times was detected for CA125 level.We found that pleural effusion and serum levels of the CA125 in patients with inflammatory pleural effusion showed no significant increase compared with normal control.For the patient with tuberculous and malignant pleural effusion,the CA125 level increased significantly compared with normal(P 0.05),furthermore,the CA125 level in effusion was slightly higher that in serum.After treatment,the CA125 level in tuberculous effusion decreased(P 0.01),but that in malignant effusion did not changed(P 0.05).The results indicate that Ca125 can be used in diagnosis and treatment of patients with tuberculous pleural effusion.
作者 张卫华
出处 《免疫学杂志》 CAS CSCD 北大核心 2011年第3期275-276,共2页 Immunological Journal
关键词 CA125 胸腔积液 结核 CA125 Pleural effusion Tuberculosis
  • 相关文献

参考文献4

二级参考文献15

  • 1梅同华,徐小杰.四项肿瘤标志物测定对癌性、结核性胸腔积液的鉴别诊断价值[J].重庆医科大学学报,2004,29(6):814-816. 被引量:11
  • 2敖日影,谢建春,余模安.肺癌患者胸水CA_(125)、CEA测定及其临床意义[J].临床肺科杂志,2005,10(1):26-27. 被引量:24
  • 3朱中元,王海波,谢勇,陈英兰,郑冰冰,张春发,张颖.表达结核分枝杆菌融合蛋白的DNA疫苗构建及免疫保护[J].免疫学杂志,2006,22(1):47-50. 被引量:5
  • 4吴传勇,娄加陶,蒋廷旺,钱,周晔,陈燕,谷明莉,邓安梅,仲人前.结核杆菌抗原多表位融合蛋白的重组表达与鉴定[J].第二军医大学学报,2006,27(12):1281-1285. 被引量:10
  • 5Visser CE,Brouwer-Steenbergen JJ,Betjes MG,el al.Cancer antigen 125:a bulk marker for the mesothelial mass in stable dialysis patient.Nephrol Dial Transplant,1995,10:64-69.
  • 6Mas MR,Comert B,Saglamkaya U,et al.CA-125,a new marker for diagnosis and follow-up of patients with tuberculosis peritonitis.Dig Liver Dis,2000,32:595-597.
  • 7Thakur V,Mukherjee U,KumarK.Elevated serum cancer antigen 125 levels in advanced abdominal tuberculosis.Med Oncol,2001,18:289-291.
  • 8Chan ED, Iseman MD. Current medical treatment for tuberculosis[J]. BMJ, 2002,325(30):1 282-1 286.
  • 9Berthet FX, Rasmussen P, Rosenkrands I, et al. A Mycobacterium tuberculosis operon encoding ESAT-6 and a novel low-molecular-mass culture fdtrate protein (CFP-10) [J] .Microbiology, 1998, 114 (Pt 11) :3 159 - 3 203.
  • 10Brandt L, Feino Cunha J, Weinreich Olsen A, et al. Failure of the Mycobacterium bovis BCG vaccine: some species of environmental mycobacteria block multiplication of BCG and induction of protective immunity to tuberculosis [ J ]. Infect Immun,2002, 70(2) :672 - 678.

共引文献50

同被引文献83

引证文献9

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部